# US 2023/0056047 A1 · Combined local delivery of therapeutic agents using interventional devices and radiation > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2023/0056047 A1 - Document ID: US20230056047A1 - Status: Published application - Kind: A1 - Application number: 17/832,804 - Filed: 2022-06-06 - Published: 2023-02-23 - Earliest claimed: 2014-12-24 - Assignees: The University of North Carolina at Chapel Hill - Applicants: The University of North Carolina at Chapel Hill - Inventors: Joseph DESIMONE; Joel TEPPER; James BYRNE - Web page: https://patentgrep.com/patent/US20230056047A1 ## CPC - A61N 5/1077: {Beam delivery systems} - A61K 9/0009: {involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis} - A61M 5/007: {for contrast media} - A61M 37/00: Other apparatus for introducing media into the body (for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30); Percutany, i.e. introducing medicines into the body by diffusion through the skin (salt baths A61H33/04) - A61N 1/0448: {Drug reservoir} - A61N 1/0509: {Stomach and intestinal electrodes} - A61N 1/306: {Arrangements where at least part of the apparatus is introduced into the body} - A61N 1/327: {for enhancing the absorption properties of tissue, e.g. by electroporation} - A61N 5/10: X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (A61N5/01 takes precedence) - A61N 5/1001: {using radiation sources introduced into or applied onto the body; brachytherapy} - A61N 5/1007: {Arrangements or means for the introduction of sources into the body} - A61M 2037/0007: {having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents} - A61N 2005/1098: {Enhancing the effect of the particle by an injected agent or implanted device} - A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B) - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} ## Abstract A method and system for combination therapy utilizing local drug delivery and radiotherapy at a target site of body tissue are provided. The delivery system comprises a source electrode adapted to be positioned proximate to a target site of internal body tissue. A counter electrode is in electrical communication with the source electrode, and is configured to cooperate with the source electrode to form a localized electric field proximate to the target site. A cargo may be delivered to the target site when exposed to the localized electric field. Radiotherapy is applied to the target site in combination with the local drug delivery. ## Claims ### Claim at position 1 1-42. (canceled) ### Claim 43 A delivery system for local drug delivery to a target site of internal body tissue, comprising: a source electrode adapted to be positioned proximate to the target site of internal body tissue, the source electrode comprising an array of probes terminating at different lengths and being independently powered such that the probes are capable of being variably controlled; a counter electrode in electrical communication with the source electrode, the counter electrode being configured to cooperate with the source electrode to form a localized electric field proximate to the target site, wherein the counter electrode includes an ion selective membrane disposed at least partially thereabout for limiting interference of non-cargo ions with the cargo to be delivered to the target site; a reservoir capable of interacting with the localized electric field, the reservoir being configured to carry a cargo capable of being delivered to the target site when exposed to the localized electric field formed between the source electrode and the counter electrode; and a radiation source external to the body and configured to apply a radiation to the target site. ### Claim 44 (depends on 43) A delivery system according to claim 43, further comprising a plurality of insulating members disposed about and between the array of probes so as to form cargo delivery zones. ### Claim 45 (depends on 43) A delivery system according to claim 43, wherein the reservoir is remotely disposed from the source electrode, the reservoir and the source electrode being in fluid communication via a hollow conduit member to facilitate transfer of the cargo from the reservoir proximate to the source electrode. ### Claim 46 (depends on 43) A delivery system according to claim 43, further comprising an electrode deployment device configured to insert at least one of the source electrode and the counter electrode proximate to the target site of internal body tissue in vivo. ### Claim 47 (depends on 46) A delivery system according to claim 46, further comprising a control system in communication with the electrode deployment device, the control system being configured to guide the electrode deployment device with placement of the source electrode and the counter electrode. ### Claim 48 (depends on 46) A delivery system according to claim 46, wherein the electrode deployment device comprises a catheter and first and second expandable members serially disposed along a longitudinal axis of the catheter, the source electrode being axially disposed between the first and second expandable members such that, upon inflation of the first and second expandable members to occlude the target site, the target site is isolated and the delivery of the cargo is contained to the target site. ### Claim 49 (depends on 48) A delivery system according to claim 48, wherein the catheter comprises a perforated polymer sheath, the cargo being capable of exiting the catheter through a plurality of perforations defined by the perforated polymer sheath, and the source electrode comprising a plurality of insulating members disposed about and between the probes so as to form cargo delivery zones substantially aligned with the perforations of the perforated polymer sheath. ### Claim 50 (depends on 46) A delivery system according to claim 46, wherein the electrode deployment device comprises an endoscope having a proximal end and a distal end, the endoscope having the source electrode disposed thereabout for positioning proximate to the target site. ### Claim 51 (depends on 50) A delivery system according to claim 50, wherein the source electrode further comprises a hollow needle member forming the reservoir, a needle proximal end of the needle having a port to fluidly connect the proximal end and a distal end of the needle such that the reservoir is capable of being remotely filled with the cargo. ### Claim 52 (depends on 43) A delivery system according to claim 43, wherein the cargo comprises at least one of small ionic molecules, nucleic acids, proteins, organic nanoparticles, therapeutic agents, and imaging agents. ### Claim 53 (depends on 43) A delivery system according to claim 43, wherein at least one probe of the array comprises one of thin wires, foil, mesh, pellets, disks, stents, clamps, prongs, clips, needles, hollow tubes, and combinations thereof. ### Claim 54 (depends on 44) A delivery system according to claim 44, wherein at least one insulating member of the plurality of insulating members is at least partially disposed about the source electrode, the at least one insulating member being configured to confer directionality to the transport profile of the cargo released from the reservoir. ### Claim 55 (depends on 54) A delivery system according to claim 54, further comprising a polymer matrix encapsulating the at least one insulating member. ### Claim 56 (depends on 43) A delivery system according to claim 43, wherein at least one probe of the array of probes comprises an imaging device such that the source electrode is capable of being imaged for positioning thereof proximate to the target site. ### Claim 57 (depends on 43) A delivery system according to claim 43, further comprising a coolant device operably engaged with the counter electrode, the coolant device being configured to provide cooling to the counter electrode during use thereof to form the electric field. ### Claim 58 (depends on 43) A delivery system according to claim 43, wherein the reservoir comprises a patch member impregnated with the cargo, the patch member being adapted for implantation proximate to the target site. ### Claim 59 (depends on 43) A delivery system according to claim 43 further comprising means for applying a voltage potential across the source and counter electrodes to form an electric field, thereby delivering at least a portion of the cargo to the target site. ### Claim 60 A method of delivering a cargo to a target site of internal body tissue, the method comprising: disposing a source electrode proximate to a target site of internal body tissue in vivo, the source electrode comprising an array of probes terminating at different lengths and being independently powered such that the probes are capable of being variably controlled; disposing a counter electrode in electrical communication with the source electrode, the counter electrode being configured to cooperate with the source electrode to form a localized electric field proximate to the target site; disposing a reservoir such that the reservoir is capable of interacting with the localized electric field, the reservoir being configured to carry a cargo capable of being delivered to the target site when exposed to the localized electric field formed between the source electrode and the counter electrode; applying a voltage potential across the source and counter electrodes to form an electric field, thereby delivering at least a portion of the cargo to the target site; and applying a radiation to the target site from a radiation source external to the body.